Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹1,815Cr
Packaging - FMCG/Consumers
Rev Gr TTM
Revenue Growth TTM
12.68%
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 3.8 | -10.6 | -6.7 | 6.9 | -4.2 | 5.8 | 12.3 | 15.3 | 14.6 | 22.3 | 9.7 | 4.1 |
| 149 | 151 | 138 | 135 | 141 | 161 | 158 | 157 | 164 | 194 | 171 | 160 |
Operating Profit Operating ProfitCr |
| 19.3 | 18.9 | 18.9 | 18.3 | 20.1 | 18.2 | 17.6 | 17.7 | 18.9 | 19.4 | 18.6 | 19.4 |
Other Income Other IncomeCr | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 |
Interest Expense Interest ExpenseCr | 1 | 2 | 2 | 2 | 2 | 3 | 4 | 3 | 4 | 4 | 4 | 4 |
Depreciation DepreciationCr | 8 | 9 | 10 | 9 | 10 | 12 | 12 | 12 | 13 | 14 | 14 | 15 |
| 27 | 25 | 21 | 19 | 24 | 22 | 19 | 18 | 22 | 30 | 21 | 19 |
| 4 | 6 | 6 | 5 | 6 | 6 | 5 | 5 | 6 | 8 | 5 | 5 |
|
Growth YoY PAT Growth YoY% | 32.8 | -13.7 | -19.2 | -12.9 | -21.9 | -11.8 | -10.1 | -3.9 | -9.5 | 35.5 | 9.7 | 5.2 |
| 12.4 | 10.1 | 9.2 | 8.6 | 10.2 | 8.4 | 7.4 | 7.2 | 8.0 | 9.3 | 7.4 | 7.2 |
| 6.9 | 5.7 | 4.7 | 4.3 | 5.4 | 5.0 | 4.3 | 4.1 | 4.9 | 6.7 | 4.7 | 4.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 12.3 | -3.3 | 9.1 | 12.8 | 16.1 | 11.0 | 9.5 | 31.9 | 15.6 | -4.3 | 11.8 | 9.0 |
| 245 | 230 | 249 | 276 | 322 | 357 | 383 | 511 | 594 | 565 | 640 | 689 |
Operating Profit Operating ProfitCr |
| 14.0 | 16.6 | 17.3 | 18.7 | 18.3 | 18.3 | 20.0 | 19.1 | 18.6 | 19.1 | 18.1 | 19.1 |
Other Income Other IncomeCr | 1 | 1 | 2 | 1 | -10 | -2 | 0 | 2 | 1 | 1 | 2 | 3 |
Interest Expense Interest ExpenseCr | 7 | 1 | 2 | 4 | 7 | 10 | 10 | 9 | 4 | 7 | 14 | 17 |
Depreciation DepreciationCr | 8 | 9 | 10 | 12 | 15 | 19 | 21 | 26 | 30 | 39 | 49 | 57 |
| 25 | 37 | 41 | 49 | 40 | 49 | 64 | 87 | 103 | 89 | 81 | 92 |
| 8 | 13 | 14 | 17 | 16 | 11 | 16 | 23 | 22 | 22 | 21 | 24 |
|
| 86.0 | 42.9 | 11.6 | 17.9 | -23.9 | 58.4 | 25.9 | 32.4 | 26.4 | -17.2 | -9.1 | 13.1 |
| 5.9 | 8.7 | 8.9 | 9.3 | 6.1 | 8.7 | 10.0 | 10.1 | 11.0 | 9.5 | 7.8 | 8.1 |
| 6.0 | 8.6 | 9.7 | 11.4 | 8.6 | 13.1 | 16.9 | 22.1 | 24.4 | 20.1 | 18.2 | 20.6 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 16 | 17 | 17 | 17 | 17 |
| 102 | 115 | 142 | 167 | 177 | 183 | 227 | 423 | 542 | 578 | 621 | 652 |
Current Liabilities Current LiabilitiesCr | 37 | 61 | 68 | 107 | 123 | 126 | 148 | 73 | 99 | 143 | 189 | 229 |
Non Current Liabilities Non Current LiabilitiesCr | 17 | 14 | 12 | 15 | 30 | 40 | 32 | 44 | 38 | 82 | 110 | 121 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 88 | 106 | 107 | 145 | 128 | 128 | 170 | 271 | 239 | 274 | 302 | 342 |
Non Current Assets Non Current AssetsCr | 82 | 98 | 129 | 157 | 215 | 235 | 266 | 303 | 456 | 546 | 635 | 677 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 32 | 38 | 26 | 9 | 71 | 47 | 61 | 3 | 152 | 79 | 110 |
Investing Cash Flow Investing Cash FlowCr | -9 | -24 | -25 | -40 | -66 | -30 | -51 | -55 | -141 | -143 | -136 |
Financing Cash Flow Financing Cash FlowCr | -23 | -14 | -1 | 31 | -6 | -17 | -10 | 56 | -10 | 59 | 25 |
|
Free Cash Flow Free Cash FlowCr | 24 | 20 | 7 | -27 | -12 | 9 | 2 | -47 | 7 | -62 | -13 |
| 191.8 | 157.3 | 98.0 | 29.4 | 295.7 | 124.0 | 126.0 | 4.0 | 188.6 | 118.4 | 182.3 |
CFO To EBITDA CFO To EBITDA% | 80.9 | 82.8 | 50.8 | 14.7 | 99.1 | 59.1 | 63.1 | 2.1 | 112.0 | 59.2 | 78.0 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 295 | 389 | 641 | 887 | 730 | 480 | 1,106 | 2,278 | 2,997 | 2,606 | 1,399 |
Price To Earnings Price To Earnings | 18.7 | 17.4 | 23.9 | 28.0 | 30.3 | 12.6 | 22.8 | 35.8 | 37.3 | 39.1 | 23.1 |
Price To Sales Price To Sales | 1.0 | 1.4 | 2.1 | 2.6 | 1.9 | 1.1 | 2.3 | 3.6 | 4.1 | 3.7 | 1.8 |
Price To Book Price To Book | 2.5 | 3.0 | 4.1 | 4.9 | 3.8 | 2.4 | 4.6 | 5.2 | 5.4 | 4.4 | 2.2 |
| 7.7 | 9.0 | 13.1 | 15.2 | 11.4 | 7.3 | 12.6 | 19.1 | 22.4 | 20.5 | 11.1 |
Profitability Ratios Profitability Ratios |
| 44.5 | 51.0 | 49.6 | 40.5 | 39.4 | 42.9 | 43.1 | 40.4 | 40.3 | 43.2 | 43.6 |
| 14.0 | 16.6 | 17.3 | 18.7 | 18.3 | 18.3 | 20.0 | 19.1 | 18.6 | 19.1 | 18.1 |
| 5.9 | 8.7 | 8.9 | 9.3 | 6.1 | 8.7 | 10.0 | 10.1 | 11.0 | 9.5 | 7.8 |
| 25.0 | 24.5 | 22.4 | 20.3 | 16.8 | 19.5 | 21.2 | 19.9 | 17.6 | 13.3 | 11.7 |
| 14.6 | 18.7 | 17.3 | 17.5 | 12.7 | 19.4 | 20.0 | 14.5 | 14.4 | 11.2 | 9.5 |
| 10.0 | 11.8 | 11.4 | 10.5 | 7.0 | 10.5 | 11.0 | 11.1 | 11.6 | 8.1 | 6.5 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Mold-Tek Packaging Limited, established in 1985 and listed in 1993, is India’s leading manufacturer of rigid plastic packaging containers. The company is recognized as the first Indian firm to introduce **In-Mold Labeling (IML)** technology with robotic automation, and it remains the only global packaging company that **in-house designs and manufactures its own IML robots and produces IML labels**. Over 39 years, Mold-Tek has built a vertically integrated, innovation-driven business model focused on high-quality, hygienic, and customized packaging across diverse industries.
---
### **Core Strengths & Competitive Advantages**
1. **End-to-End Vertical Integration**
Mold-Tek controls every stage of the packaging value chain—from design and mold manufacturing to production and delivery. This full backward integration includes:
- In-house **tool room** equipped with 3-axis and 5-axis CNC machines
- **Robotics and automation** for IML and production
- **IML label production**, heat transfer labeling (HTL), and advanced printing capabilities
- Centralized **design studio (D3: Design, Develop, Deliver)** with 200+ concepts developed and 3 India Star Awards won
2. **Speed and Customization**
The in-house tool room enables rapid product development—**custom pharma packaging in weeks vs. industry averages of 2–3 months**—giving Mold-Tek a decisive edge in serving clients with time-sensitive or regulated packaging needs.
3. **Technology & Innovation**
- Pioneered **laser-marked, single-piece desiccant canisters** and **IML-equipped EV tubes**
- Developed **digital IML with dual QR codes** (visible for engagement, hidden for authentication)
- Implements **100% camera-based inspection systems** for pharma-grade quality
---
### **Business Segments & Product Portfolio**
Mold-Tek serves multiple B2B sectors, including:
- **Pharmaceuticals** (tablets, EV tubes, canisters, CRC/CT closures)
- **Electric Vehicles (EV)** – nutraceuticals, batteries, motors
- **Food, FMCG, and Retail** – edible oil, protein powders, ready-to-eat, ice cream, restaurant packs
- **Paints, Lubricants, and Chemicals**
- **Pumps and Dispensers** – twist-lock, sprayers
Key products:
- **Q-Packs** (1–20L for cashew, oil, detergents)
- **Effervescent Tubes & Canisters** with IML
- **IML, HTL, DOP, Screen Printed Containers**
- **Pumps** for hygiene, personal care
- **Custom containers** for cosmetics, dairy, agri-products
---
### **Strategic Growth Drivers (Nov 2025 Update)**
#### 1. **Electric Vehicle (EV) Packaging – High-Growth Engine**
- EV-related products—**tubes, caps, and bottles**—are key growth drivers.
- Two major EV customers are expected to generate **₹10+ crore each in annual revenue**, starting from **₹70–80 lakhs per quarter**, scaling to **₹2–3 crore per quarter by Q4 FY26**.
- Over **50 customer visits** with **20–25 clients already in production**, no single client exceeds 10% of sales.
- Works with **4 of India’s top 5 EV segment CMOs**, with canister orders beginning to scale.
#### 2. **Pharmaceutical Packaging – Rapid Expansion & High Margins**
- The pharma division has **breakeven within its first year**, a significant achievement versus the 3-year industry norm.
- Revenue rose to **₹6.67 crore in Q4 FY25**, contributing to ~₹30 crore in full-year FY26 guidance and **projected to exceed ₹50 crore by FY27**.
- Achieved **over 20 client audits**, with **2–3 commercial clients** driving volume growth and **15+ more in pipeline**.
- Secured **US-DMF, Health Canada, and ISO 8 cleanroom certifications**; new Sultanpur plant is **Type III US-DMF accredited**.
- Products include **IML-decorated effervescent tubes, child-resistant 'Squeeze & Lock' caps, and laser-engraved canisters**.
- **Export potential**: First commercial supply to U.S.; pursuing Europe (Germany in stability testing); targeting import substitution and Bangladesh exports.
#### 3. **Capacity & Infrastructure Expansion**
- Total installed capacity: **55,000 metric tons per annum (TPA)** across **13 manufacturing facilities**.
- **ABG (automotive/industrial) capacity** stands at **10,000 tons** across 3 plants; **60–65% full-year utilization projected**, up from 2,900 tons in H1.
- **Panipat Plant Expansion**:
- Current capacity: **5,000 tons**, expanding to **6,500–7,000 tons**
- Adding **1,000 tons for Food & FMCG**, **700–800 tons for pails**
- **CapEx Guidance**: **₹70–80 crore for FY26**, including:
- **₹25 crore** for pharma expansion
- **₹14–15 crore** for Mahad plant
- **₹7–8 crore** for printing
- Land acquired in **Sultanpur** for brownfield pharma expansion; major investments from **FY27**
#### 4. **New Facility & Product Pipeline**
- **New pharma facility** on recently acquired **Sultanpur land**—construction starts **Dec–Jan 2025–26**, **operational by H2 FY26**.
- 2025 commissioning of **state-of-the-art pharma plant** in Sultanpur with:
- Class 100k cleanrooms
- ISO 8 certification
- US-DMF and Health Canada compliance
- **Pump Segment**:
- Generates **₹30–40 lakhs/month** from pharma and cosmetics
- Minimal U.S. exposure (**₹2–3 crores/year**), unaffected by tariffs
#### 5. **Cost & Operational Improvements**
- Integration of **IML + in-house HTL label manufacturing** at Sultanpur will reduce **consumable costs by ₹1/kg (~7–10%)**.
- Benefits expected from **Q3–Q4 FY26**.
- Deployment of **automated systems, 100% camera inspections**, and **digital printing** for fast turnaround.
---
### **Recent Performance & Outlook**
- **FY25 Revenue Growth**: **17.34%**, driven by detergent and cashew packaging
- **Food & FMCG Segment**: Grew **11.76%**, supported by new beverage and nutritional packs
- **Restaurant Packs**: **140% YoY growth** (launched 2023–24)
- **Key Clients Added (2025)**: Marico, ID Fresh, Mankind, Inventia, Laurus, Amnlife, Pulse Pharma
- **Export Growth**: **55% increase in thinwall**, **doubled in first 9 months FY25**—driven by lubricant pails, pharma EV tubes, and U.S. canister orders
---
### **Leadership & Strategic Oversight**
- **Mr. J. Rana Pratap**, SVP – Corporate: Leads strategy, pharma packaging (effervescent tubes, bottles, canisters), and top strategic accounts. IIT Delhi + IIM Lucknow, with 13+ years at Mold-Tek.
- **Mr. A. Durga Sundeep**, SVP – Operations & Finance: Oversees planning across **16 facilities**, 2,000+ SKUs, digital systems for forecasting, costing, and margin analysis.
- **Mr. Subramanyam Adivishnu**, Promoter: Oversees **in-house tool room and R&D**; pioneered IML and robotics in India.